Advertisement

Use of the Cystic Fibrosis Foundation's extensive sputum-culturing protocol for patients without cystic fibrosis: Implications for infection control and antimicrobial resistance

  • Jennifer Brown
    Correspondence
    Address correspondence to Jennifer Brown, MD, Division of Infectious Diseases Department of Internal Medicine, University of California, Davis Medical Center, 4150 V. Street, PSSB G500, Sacramento, CA 95817.
    Affiliations
    Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis Medical Center, Sacramento, CA
    Search for articles by this author
      The US Cystic Fibrosis Foundation has guidelines for culturing respiratory tract specimens from patients with cystic fibrosis. Pulmonary physicians were surveyed regarding their use of these extensive cystic fibrosis culture protocols for patients without cystic fibrosis. The survey results and a discussion of the implications of these practices are reported.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Saiman L.
        • Seigel J.
        Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.
        Infect Control Hosp Epidemiol. 2003; 24: S6-52
        • Martínez-García M.A.
        • Soler-Cataluña J.J.
        • Perpiñá-Tordera M.
        • Román-Sánchez P.
        • Soriano J.
        Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.
        Chest. 2007; 132: 1565-1572
        • Bilton D.
        Update on non-cystic fibrosis bronchiectasis.
        Curr Opin Pulm Med. 2008; 14: 595-599
        • Pasteur M.C.
        • Bilton D.
        • Hill A.T.
        British Thoracic Society guideline for non-CF bronchiectasis.
        Thorax. 2010; 65: i1-58
        • Rogers G.B.
        • van der Gast C.J.
        • Cuthbertson L.
        • Thomson S.K.
        • Bruce K.D.
        • Martin M.L.
        • et al.
        Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
        Thorax. 2013; 68: 731-737
        • Gillham M.I.
        • Sundaram S.
        • Laughton C.R.
        • Haworth C.S.
        • Bilton D.
        • Foweraker J.E.
        Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
        J Antimicrob Chemother. 2009; 63: 728-732
        • Seitz A.E.
        • Olivier K.N.
        • Steiner C.A.
        • Montes de Oca R.
        • Holland S.M.
        • Prevots D.R.
        Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006.
        Chest. 2010; 138: 944-949
        • Evans D.J.
        • Bara A.I.
        • Greenstone M.
        Prolonged antibiotics for purulent bronchiectasis in children and adults.
        Cochrane Database Syst Rev. 2007; : CD001392
        • Emerson J.
        • McNamara S.
        • Buccat A.M.
        • Worrell K.
        • Burns J.L.
        Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.
        Pediatr Pulmonol. 2010; 45: 363-370
        • Smith A.L.
        • Fiel S.B.
        • Mayer-Hamblett N.
        • Ramsey B.
        • Burns J.L.
        Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.
        Chest. 2003; 123: 1495-1502
        • Zhou J.
        • Garber E.
        • Desai M.
        • Saiman L.
        Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.
        J Clin Microbiol. 2006; 44: 1547-1549